BofA Securities analyst Adam ROn lowered the price target on Astrana Health, Inc (NASDAQ: ASTH) to $49.00 (from $55.00) while ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE